$SRRA Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Sierra Oncology, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Sierra Oncology, Inc.. Get notifications about new insider transactions in Sierra Oncology, Inc. for free.

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 09 2021	SRRA	Sierra Oncology, I ...	Cooper Jeffrey H	Director	Option Exercise	A	18.11	6,000	108,660	6,000
Jun 09 2021	SRRA	Sierra Oncology, I ...	Collard Craig A	Director	Option Exercise	A	18.11	6,000	108,660	6,000
Jun 09 2021	SRRA	Sierra Oncology, I ...	Richardson Joshua	Director	Option Exercise	A	18.11	6,000	108,660	6,000
Jun 04 2021	SRRA	Sierra Oncology, I ...	Oliger Christy J.	Director	Option Exercise	A	17.76	18,000	319,635	18,000
Jun 04 2021	SRRA	Sierra Oncology, I ...	Oliger Christy J.	Director	Option Exercise	A	17.76	18,000	319,635	18,000
May 20 2021	SRRA	Sierra Oncology, I ...	DILLY STEPHEN GEORGE	CEO and President	Buy	P	17.83	5,000	89,150	5,000	0 to 5 K
Mar 17 2021	SRRA	Sierra Oncology, I ...	Turner William D.	Chief Reg & Tech Op ...	Option Exercise	A	16.73	12,300	205,779	12,300
Mar 17 2021	SRRA	Sierra Oncology, I ...	Thomson Christina	General Counsel	Option Exercise	A	16.73	12,900	215,817	12,900
Mar 17 2021	SRRA	Sierra Oncology, I ...	Norrett Kevin	Chief Business Offi ...	Option Exercise	A	16.73	11,700	195,741	11,700
Mar 17 2021	SRRA	Sierra Oncology, I ...	Kowalski Mark	Chief Medical Offic ...	Option Exercise	A	16.73	30,000	501,900	30,000
Mar 17 2021	SRRA	Sierra Oncology, I ...	Klencke Barbara	Chief Development O ...	Option Exercise	A	16.73	30,000	501,900	30,000
Mar 17 2021	SRRA	Sierra Oncology, I ...	Jagpal Sukhi	Chief Financial Off ...	Option Exercise	A	16.73	30,000	501,900	30,000
Mar 17 2021	SRRA	Sierra Oncology, I ...	DILLY STEPHEN GEORGE	CEO and President	Option Exercise	A	16.73	92,000	1,539,160	92,000
Aug 18 2020	SRRA	Sierra Oncology, I ...	Klencke Barbara	Chief Development O ...	Buy	P	12.25	3,325	40,738	5,000	1.7 K to 5 K (+198.51 %)
Aug 18 2020	SRRA	Sierra Oncology, I ...	Klencke Barbara	Chief Development O ...	Buy	P	12.22	5,950	72,710	10,000	4.1 K to 10 K (+146.91 %)
Aug 12 2020	SRRA	Sierra Oncology, I ...	Kowalski Mark	Chief Medical Offic ...	Option Exercise	A	12.15	24,970	303,386	24,970
Aug 12 2020	SRRA	Sierra Oncology, I ...	Jagpal Sukhi	Chief Financial Off ...	Option Exercise	A	12.15	5,887	71,527	5,887
Aug 12 2020	SRRA	Sierra Oncology, I ...	Kowalski Mark	Chief Medical Offic ...	Option Exercise	A	12.15	24,970	303,386	24,970
Aug 12 2020	SRRA	Sierra Oncology, I ...	Jagpal Sukhi	Chief Financial Off ...	Option Exercise	A	12.15	5,887	71,527	5,887
Aug 11 2020	SRRA	Sierra Oncology, I ...	Norrett Kevin	Chief Business Offi ...	Option Exercise	A	12.05	100,000	1,205,000	100,000
Aug 06 2020	SRRA	Sierra Oncology, I ...	Turner William D.	Chief Reg & Tech Op ...	Option Exercise	A	12.05	100,000	1,205,000	100,000
Jul 29 2020	SRRA	Sierra Oncology, I ...	Thomson Christina	General Counsel	Option Exercise	A	13.04	100,000	1,304,000	100,000
Jun 10 2020	SRRA	Sierra Oncology, I ...	Richardson Joshua	Director	Option Exercise	A	13.98	6,874	96,099	6,874
Jun 10 2020	SRRA	Sierra Oncology, I ...	Pelzer Robert	Director	Option Exercise	A	13.98	16,686	233,270	16,686
Jun 10 2020	SRRA	Sierra Oncology, I ...	Cooper Jeffrey H	Director	Option Exercise	A	13.98	18,061	252,493	18,061
Jun 10 2020	SRRA	Sierra Oncology, I ...	Ashiya Mona	Director	Option Exercise	A	13.98	6,874	96,099	6,874
Jun 10 2020	SRRA	Sierra Oncology, I ...	Allen Andrew R	Director	Option Exercise	A	13.98	12,030	168,179	12,030
Jun 10 2020	SRRA	Sierra Oncology, I ...	Aggarwal Gaurav	Director	Option Exercise	A	13.98	6,874	96,099	6,874
Jun 10 2020	SRRA	Sierra Oncology, I ...	Sinclair Andrew	Director	Option Exercise	A	13.98	6,874	96,099	6,874
Jun 02 2020	SRRA	Sierra Oncology, I ...	DILLY STEPHEN GEORGE	CEO and President	Option Exercise	A	14.03	520,000	7,295,600	520,000
May 29 2020	SRRA	Sierra Oncology, I ...	Collard Craig A	Director	Option Exercise	A	13.88	10,000	138,800	10,000
Feb 27 2020	SRRA	Sierra Oncology, I ...	Klencke Barbara	Chief Development O ...	Option Exercise	A	13.31	167,091	2,223,981	167,091
Feb 27 2020	SRRA	Sierra Oncology, I ...	Jagpal Sukhi	Chief Financial Off ...	Option Exercise	A	13.31	94,113	1,252,644	94,113
Jan 31 2020	SRRA	Sierra Oncology, I ...	Sinclair Andrew	Director	Option Exercise	C	0.00	11,500	0	0
Jan 31 2020	SRRA	Sierra Oncology, I ...	Sinclair Andrew	Director	Buy	C	0.00	871,125	0	876,542	5.4 K to 876.5 K (+16,081.32 %)
Jan 31 2020	SRRA	Sierra Oncology, I ...	Vivo Opportunity, LLC	10% Owner	Option Exercise	C	0.00	4,287	0	0
Jan 31 2020	SRRA	Sierra Oncology, I ...	Vivo Opportunity, LLC	10% Owner	Option Exercise	C	0.00	19,213	0	0
Jan 31 2020	SRRA	Sierra Oncology, I ...	Vivo Opportunity, LLC	10% Owner	Option Exercise	C	0.00	1,000	0	0
Jan 31 2020	SRRA	Sierra Oncology, I ...	Vivo Opportunity, LLC	10% Owner	Buy	C	0.00	324,783	0	324,783	0 to 324.8 K
Jan 31 2020	SRRA	Sierra Oncology, I ...	Vivo Opportunity, LLC	10% Owner	Buy	C	0.00	1,455,576	0	1,455,576	0 to 1.5 M
Jan 31 2020	SRRA	Sierra Oncology, I ...	Vivo Opportunity, LLC	10% Owner	Buy	C	0.00	75,759	0	136,715	61 K to 136.7 K (+124.28 %)
Jan 31 2020	SRRA	Sierra Oncology, I ...	Longitude Capital Partners III ...	10% Owner	Option Exercise	C	0.00	19,500	0	0
Jan 31 2020	SRRA	Sierra Oncology, I ...	Longitude Capital Partners III ...	10% Owner	Buy	C	0.00	1,477,320	0	1,477,320	0 to 1.5 M
Jan 31 2020	SRRA	Sierra Oncology, I ...	Richardson Joshua	Director	Option Exercise	C	0.00	19,500	0	0
Jan 31 2020	SRRA	Sierra Oncology, I ...	Richardson Joshua	Director	Buy	C	0.00	1,477,320	0	1,477,320	0 to 1.5 M
Jan 31 2020	SRRA	Sierra Oncology, I ...	Ashiya Mona	Director	Option Exercise	C	0.00	19,500	0	0
Jan 31 2020	SRRA	Sierra Oncology, I ...	Ashiya Mona	Director	Buy	C	0.00	1,477,320	0	1,477,320	0 to 1.5 M
Jan 31 2020	SRRA	Sierra Oncology, I ...	Aggarwal Gaurav	Director	Option Exercise	C	0.00	19,213	0	0
Jan 31 2020	SRRA	Sierra Oncology, I ...	Aggarwal Gaurav	Director	Buy	C	0.00	1,455,576	0	1,455,576	0 to 1.5 M
Jan 31 2020	SRRA	Sierra Oncology, I ...	ORBIMED ADVISORS LLC	Director	Option Exercise	C	0.00	19,500	0	0
Jan 31 2020	SRRA	Sierra Oncology, I ...	ORBIMED ADVISORS LLC	Director	Buy	C	0.00	1,477,320	0	1,477,320	0 to 1.5 M
Dec 03 2019	SRRA	Sierra Oncology, I ...	Sinclair Andrew	Director	Option Exercise	A	0.35	60,000	20,802	60,000
Dec 03 2019	SRRA	Sierra Oncology, I ...	Sinclair Andrew	Director	Option Exercise	A	0.35	60,000	20,802	60,000
Dec 03 2019	SRRA	Sierra Oncology, I ...	Richardson Joshua	Director	Option Exercise	A	0.35	60,000	20,802	60,000
Dec 03 2019	SRRA	Sierra Oncology, I ...	Ashiya Mona	Director	Option Exercise	A	0.35	60,000	20,802	60,000
Dec 03 2019	SRRA	Sierra Oncology, I ...	Aggarwal Gaurav	Director	Option Exercise	A	0.35	60,000	20,802	60,000
Aug 26 2019	SRRA	Sierra Oncology, I ...	Klencke Barbara	Chief Development O ...	Buy	P	0.44	108,000	47,380	162,000	54 K to 162 K (+200.00 %)
Aug 26 2019	SRRA	Sierra Oncology, I ...	Klencke Barbara	Chief Development O ...	Buy	P	0.45	54,000	24,295	54,000	0 to 54 K
Aug 26 2019	SRRA	Sierra Oncology, I ...	Klencke Barbara	Chief Development O ...	Buy	P	0.43	67,000	28,964	67,000	0 to 67 K
Jun 12 2019	SRRA	Sierra Oncology, I ...	Pelzer Robert	Director	Option Exercise	A	0.66	30,000	19,800	30,000
Jun 12 2019	SRRA	Sierra Oncology, I ...	Parfet Donald R	Director	Option Exercise	A	0.66	30,000	19,800	30,000
Jun 12 2019	SRRA	Sierra Oncology, I ...	ONETTO NICOLE	Director	Option Exercise	A	0.66	30,000	19,800	30,000
Jun 12 2019	SRRA	Sierra Oncology, I ...	Nguyen Tran	Director	Option Exercise	A	0.66	30,000	19,800	30,000
Jun 12 2019	SRRA	Sierra Oncology, I ...	ESTES DANIEL	Director	Option Exercise	A	0.66	30,000	19,800	30,000
Jun 12 2019	SRRA	Sierra Oncology, I ...	Cooper Jeffrey H	Director	Option Exercise	A	0.66	30,000	19,800	30,000
Jun 12 2019	SRRA	Sierra Oncology, I ...	Allen Andrew R	Director	Option Exercise	A	0.66	30,000	19,800	30,000
Mar 05 2019	SRRA	Sierra Oncology, I ...	Kowalski Mark	Chief Medical Offic ...	Option Exercise	A	1.96	200,000	392,000	200,000
Mar 05 2019	SRRA	Sierra Oncology, I ...	Jagpal Sukhi	Chief Financial Off ...	Option Exercise	A	1.96	200,000	392,000	200,000
Mar 05 2019	SRRA	Sierra Oncology, I ...	Hassig Christian	Chief Scientific Of ...	Option Exercise	A	1.96	155,000	303,800	155,000
Mar 05 2019	SRRA	Sierra Oncology, I ...	Glover Nicholas	CEO and President	Option Exercise	A	1.96	607,500	1,190,700	607,500
Dec 11 2018	SRRA	Sierra Oncology, I ...	Allen Andrew R	Director	Buy	P	1.64	66,000	108,240	66,000	0 to 66 K
Jun 14 2018	SRRA	Sierra Oncology, I ...	ESTES DANIEL	Director	Option Exercise	A	3.27	25,000	81,750	25,000
Jun 14 2018	SRRA	Sierra Oncology, I ...	Pelzer Robert	Director	Option Exercise	A	3.27	25,000	81,750	25,000
Jun 14 2018	SRRA	Sierra Oncology, I ...	Parfet Donald R	Director	Option Exercise	A	3.27	25,000	81,750	25,000
Jun 14 2018	SRRA	Sierra Oncology, I ...	ONETTO NICOLE	Director	Option Exercise	A	3.27	25,000	81,750	25,000
Jun 14 2018	SRRA	Sierra Oncology, I ...	Nguyen Tran	Director	Option Exercise	A	3.27	25,000	81,750	25,000
Jun 14 2018	SRRA	Sierra Oncology, I ...	Cooper Jeffrey H	Director	Option Exercise	A	3.27	25,000	81,750	25,000
Jun 14 2018	SRRA	Sierra Oncology, I ...	Allen Andrew R	Director	Option Exercise	A	3.27	25,000	81,750	25,000
Mar 07 2018	SRRA	Sierra Oncology, I ...	You Angie	Chief Bus. & Strat. ...	Option Exercise	A	2.36	180,360	425,650	180,360
Mar 07 2018	SRRA	Sierra Oncology, I ...	Kowalski Mark	Chief Medical Offic ...	Option Exercise	A	2.36	155,000	365,800	155,000
Mar 07 2018	SRRA	Sierra Oncology, I ...	Klencke Barbara	Chief Development O ...	Option Exercise	A	2.36	180,360	425,650	180,360
Mar 07 2018	SRRA	Sierra Oncology, I ...	Jagpal Sukhi	Chief Financial Off ...	Option Exercise	A	2.36	180,360	425,650	180,360
Mar 07 2018	SRRA	Sierra Oncology, I ...	Hassig Christian	Chief Scientific Of ...	Option Exercise	A	2.36	205,180	484,225	205,180
Mar 07 2018	SRRA	Sierra Oncology, I ...	Glover Nicholas	CEO and President	Option Exercise	A	2.36	562,780	1,328,161	562,780
Jan 08 2018	SRRA	Sierra Oncology, I ...	Parfet Donald R	Director	Buy	J	0.00	1,380	0	77,235	75.9 K to 77.2 K (+1.82 %)
Jan 08 2018	SRRA	Sierra Oncology, I ...	Parfet Donald R	Director	Sell	J	0.00	2,760	0	0	2.8 K to 0 (-100.00 %)
Jan 08 2018	SRRA	Sierra Oncology, I ...	Parfet Donald R	Director	Buy	J	0.00	1,068	0	2,760	1.7 K to 2.8 K (+63.12 %)
Jan 08 2018	SRRA	Sierra Oncology, I ...	Parfet Donald R	Director	Buy	J	0.00	1,692	0	1,692	0 to 1.7 K
Jan 08 2018	SRRA	Sierra Oncology, I ...	Parfet Donald R	Director	Buy	J	0.00	3,383	0	390,913	387.5 K to 390.9 K (+0.87 %)
Nov 13 2017	SRRA	Sierra Oncology, I ...	Allen Andrew R	Director	Option Exercise	A	1.92	50,000	96,000	50,000
Jun 14 2017	SRRA	Sierra Oncology, I ...	Pelzer Robert	Director	Option Exercise	A	1.13	25,000	28,250	25,000
Jun 14 2017	SRRA	Sierra Oncology, I ...	Parfet Donald R	Director	Option Exercise	A	1.13	25,000	28,250	25,000
Jun 14 2017	SRRA	Sierra Oncology, I ...	ONETTO NICOLE	Director	Option Exercise	A	1.13	25,000	28,250	25,000
Jun 14 2017	SRRA	Sierra Oncology, I ...	Nguyen Tran	Director	Option Exercise	A	1.13	25,000	28,250	25,000
Jun 14 2017	SRRA	Sierra Oncology, I ...	Cooper Jeffrey H	Director	Option Exercise	A	1.13	25,000	28,250	25,000
May 30 2017	SRRA	Sierra Oncology, I ...	ESTES DANIEL	Director	Option Exercise	A	1.20	50,000	60,000	50,000
Mar 09 2017	SRRA	Sierra Oncology, I ...	You Angie	Chief Bus. & Strat. ...	Buy	P	1.43	30,000	42,900	133,252	103.3 K to 133.3 K (+29.06 %)
Mar 08 2017	SRRA	Sierra Oncology, I ...	Klencke Barbara	Chief Development O ...	Option Exercise	A	1.45	70,000	101,500	70,000
Mar 08 2017	SRRA	Sierra Oncology, I ...	Jagpal Sukhi	Chief Financial Off ...	Option Exercise	A	1.45	70,000	101,500	70,000
Mar 08 2017	SRRA	Sierra Oncology, I ...	You Angie	Chief Bus. & Strat. ...	Option Exercise	A	1.45	70,000	101,500	70,000
Mar 08 2017	SRRA	Sierra Oncology, I ...	Glover Nicholas	CEO and President	Option Exercise	A	1.45	195,000	282,750	195,000
Feb 16 2017	DNAI	Sierra Oncology, I ...	Topper James N	Director	Buy	P	1.35	5,925,926	8,000,000	5,925,926	0 to 5.9 M
Jan 04 2017	DNAI	ProNAi Therapeutic ...	Kowalski Mark	Chief Medical Offic ...	Option Exercise	A	1.54	300,000	462,000	300,000
Nov 10 2016	DNAI	ProNAi Therapeutic ...	Parfet Donald R	Chairman of the Boa ...	Buy	J	0.00	2,403	0	75,855	73.5 K to 75.9 K (+3.27 %)
Nov 10 2016	DNAI	ProNAi Therapeutic ...	Parfet Donald R	Chairman of the Boa ...	Sell	J	0.00	4,806	0	0	4.8 K to 0 (-100.00 %)
Nov 10 2016	DNAI	ProNAi Therapeutic ...	Parfet Donald R	Chairman of the Boa ...	Buy	J	0.00	1,423	0	4,806	3.4 K to 4.8 K (+42.06 %)
Nov 10 2016	DNAI	ProNAi Therapeutic ...	Parfet Donald R	Chairman of the Boa ...	Buy	J	0.00	3,383	0	3,383	0 to 3.4 K
Nov 10 2016	DNAI	ProNAi Therapeutic ...	Parfet Donald R	Chairman of the Boa ...	Buy	J	0.00	6,767	0	387,530	380.8 K to 387.5 K (+1.78 %)
Oct 04 2016	DNAI	ProNAi Therapeutic ...	Klencke Barbara	Chief Development O ...	Option Exercise	A	1.82	456,000	829,920	456,000
Oct 04 2016	DNAI	ProNAi Therapeutic ...	Glover Nicholas	CEO and President	Option Exercise	A	1.82	500,000	910,000	500,000
Oct 04 2016	DNAI	ProNAi Therapeutic ...	Jagpal Sukhi	Chief Financial Off ...	Option Exercise	A	1.82	168,000	305,760	168,000
Oct 04 2016	DNAI	ProNAi Therapeutic ...	You Angie	Chief Bus. & Strat. ...	Option Exercise	A	1.82	200,000	364,000	200,000
Sep 30 2016	DNAI	ProNAi Therapeutic ...	Parfet Donald R	Chairman of the Boa ...	Buy	J	0.00	1,202	0	73,452	72.3 K to 73.5 K (+1.66 %)
Sep 30 2016	DNAI	ProNAi Therapeutic ...	Parfet Donald R	Chairman of the Boa ...	Sell	J	0.00	2,403	0	0	2.4 K to 0 (-100.00 %)
Sep 30 2016	DNAI	ProNAi Therapeutic ...	Parfet Donald R	Chairman of the Boa ...	Buy	J	0.00	711	0	2,403	1.7 K to 2.4 K (+42.02 %)
Sep 30 2016	DNAI	ProNAi Therapeutic ...	Parfet Donald R	Chairman of the Boa ...	Buy	J	0.00	1,692	0	1,692	0 to 1.7 K
Sep 30 2016	DNAI	ProNAi Therapeutic ...	Parfet Donald R	Chairman of the Boa ...	Buy	J	0.00	3,384	0	380,763	377.4 K to 380.8 K (+0.90 %)
Jun 20 2016	DNAI	ProNAi Therapeutic ...	Topper James N	Director	Option Exercise	A	2.06	38,835	80,000	38,835
Jun 20 2016	DNAI	ProNAi Therapeutic ...	Pelzer Robert	Director	Option Exercise	A	2.06	38,835	80,000	38,835
Jun 20 2016	DNAI	ProNAi Therapeutic ...	Parfet Donald R	Chairman of the Boa ...	Option Exercise	A	2.06	38,835	80,000	38,835
Jun 20 2016	DNAI	ProNAi Therapeutic ...	ONETTO NICOLE	Director	Option Exercise	A	2.06	38,835	80,000	38,835
Jun 13 2016	DNAI	ProNAi Therapeutic ...	Nguyen Tran	Director	Option Exercise	A	2.06	77,670	160,000	77,670
Jun 13 2016	DNAI	ProNAi Therapeutic ...	Cooper Jeffrey H	Director	Option Exercise	A	2.06	77,670	160,000	77,670
May 17 2016	DNAI	ProNAi Therapeutic ...	Parfet Donald R	Chairman of the Boa ...	Buy	J	0.00	3,204	0	377,379	374.2 K to 377.4 K (+0.86 %)
Mar 24 2016	DNAI	ProNAi Therapeutic ...	Chapman Wendy	SVP Clinical Operat ...	Option Exercise	M	0.97	3,000	2,907	76,248
Mar 24 2016	DNAI	ProNAi Therapeutic ...	Chapman Wendy	SVP Clinical Operat ...	Sell	S	7.01	3,000	21,023	0	3 K to 0 (-100.00 %)
Mar 24 2016	DNAI	ProNAi Therapeutic ...	Chapman Wendy	SVP Clinical Operat ...	Buy	M	0.97	3,000	2,907	3,000	0 to 3 K
Mar 10 2016	DNAI	ProNAi Therapeutic ...	Chapman Wendy	SVP Clinical Operat ...	Option Exercise	A	6.58	25,000	164,500	25,000
Mar 10 2016	DNAI	ProNAi Therapeutic ...	Jagpal Sukhi	Chief Financial Off ...	Option Exercise	A	6.58	48,750	320,775	48,750
Mar 10 2016	DNAI	ProNAi Therapeutic ...	Messmann Richard A	Chief Medical Offic ...	Option Exercise	A	6.58	25,000	164,500	25,000
Mar 10 2016	DNAI	ProNAi Therapeutic ...	Glover Nicholas	CEO and President	Option Exercise	A	6.58	161,250	1,061,025	161,250
Mar 10 2016	DNAI	ProNAi Therapeutic ...	Lovejoy Chandra D	SVP of Reg. Affairs ...	Option Exercise	A	6.58	31,000	203,980	31,000
Mar 10 2016	DNAI	ProNAi Therapeutic ...	Klencke Barbara	Chief Development O ...	Option Exercise	A	6.58	82,500	542,850	82,500
Mar 10 2016	DNAI	ProNAi Therapeutic ...	You Angie	Chief Bus. & Strat. ...	Option Exercise	A	6.58	75,000	493,500	75,000
Feb 24 2016	DNAI	ProNAi Therapeutic ...	Chapman Wendy	SVP Clinical Operat ...	Option Exercise	M	0.97	3,000	2,907	79,248
Feb 24 2016	DNAI	ProNAi Therapeutic ...	Chapman Wendy	SVP Clinical Operat ...	Sell	S	7.06	3,000	21,180	0	3 K to 0 (-100.00 %)
Feb 24 2016	DNAI	ProNAi Therapeutic ...	Chapman Wendy	SVP Clinical Operat ...	Buy	M	0.97	3,000	2,907	3,000	0 to 3 K
Jan 25 2016	DNAI	ProNAi Therapeutic ...	Chapman Wendy	SVP Clinical Operat ...	Option Exercise	M	0.97	5,000	4,845	82,248
Jan 25 2016	DNAI	ProNAi Therapeutic ...	Chapman Wendy	SVP Clinical Operat ...	Sell	S	9.39	5,000	46,973	0	5 K to 0 (-100.00 %)
Jan 25 2016	DNAI	ProNAi Therapeutic ...	Chapman Wendy	SVP Clinical Operat ...	Buy	M	0.97	5,000	4,845	5,000	0 to 5 K
Jan 22 2016	DNAI	ProNAi Therapeutic ...	Rodigueza Wendi	Chief Scientific Of ...	Sell	S	9.66	1,000	9,660	156,276	157.3 K to 156.3 K (-0.64 %)
Jan 22 2016	DNAI	ProNAi Therapeutic ...	Rodigueza Wendi	Chief Scientific Of ...	Sell	S	10.32	1,000	10,323	157,276	158.3 K to 157.3 K (-0.63 %)
Jan 22 2016	DNAI	ProNAi Therapeutic ...	Rodigueza Wendi	Chief Scientific Of ...	Sell	S	9.59	1,000	9,590	158,276	159.3 K to 158.3 K (-0.63 %)
Jan 19 2016	DNAI	ProNAi Therapeutic ...	Glover Nicholas	CEO and President	Option Exercise	M	0.97	5,000	4,845	864,219
Jan 19 2016	DNAI	ProNAi Therapeutic ...	Glover Nicholas	CEO and President	Sell	S	10.04	5,000	50,223	0	5 K to 0 (-100.00 %)
Jan 19 2016	DNAI	ProNAi Therapeutic ...	Glover Nicholas	CEO and President	Buy	M	0.97	5,000	4,845	5,000	0 to 5 K
Jan 14 2016	DNAI	ProNAi Therapeutic ...	Lovejoy Chandra D	SVP of Reg. Affairs ...	Option Exercise	M	0.97	7,551	7,317	46,140
Jan 14 2016	DNAI	ProNAi Therapeutic ...	Lovejoy Chandra D	SVP of Reg. Affairs ...	Sell	S	11.93	5,562	66,345	0	5.6 K to 0 (-100.00 %)
Jan 14 2016	DNAI	ProNAi Therapeutic ...	Lovejoy Chandra D	SVP of Reg. Affairs ...	Sell	S	11.06	15,411	170,489	5,562	21 K to 5.6 K (-73.48 %)
Jan 14 2016	DNAI	ProNAi Therapeutic ...	Lovejoy Chandra D	SVP of Reg. Affairs ...	Buy	M	0.97	7,551	7,317	20,973	13.4 K to 21 K (+56.26 %)

Page: 1 2 next >